Juan Gómez Rivas: A Must-Read for Exploring Less Invasive Options in Prostate Cancer
Juan Gómez Rivas, Associate Professor at Complutense University of Madrid, shared on X about recent paper by Mark Taratkin et al., published in Journal of Endourology.
“Urinary Outcomes of Minimally Invasive Treatments for Prostate Cancer.
Minimally invasive treatments (MITs) are reshaping prostate cancer care. This review evaluates the impact of different MITs on urinary continence, a key concern for patients.
- 36 studies reviewed
- Techniques studied: brachytherapy, cryoablation, HIFU, IRE, TULSA, and more
- Focal therapies like mpMRI-US-guided HIFU, focal cryoablation, and IRE show best continence outcomes
- Most patients remained continent after treatment, especially with focal approaches
- Takeaway: MITs can offer cancer control while preserving quality of life
A must-read for urologists, oncologists, and patients exploring less invasive options.”
Title: Urinary Outcomes of Minimally Invasive Treatments for Prostate Cancer—A Systematic Review by Young Academic Urologists’ Urotechnology Working Group
Authors: Mark Taratkin, Alexander Androsov, Andrey Morozov, Camilla Azilgareeva, Juan Gomez Rivas, Stefano Puliatti, Enrico Checcucci, Ines Rivero Belenchon, Karl-Friedrich Kowalewski, Severin Rodler, Pietro Piazza, Loïc Baekelandt, Alessandro Veccia, Pieter De Backer, Harun Fajkovic, Dmitry Enikeev, Giovanni E. Cacciamani
Read The Full Article at Journal of Endourology.
More Posts Featuring Juan Gómez Rivas.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023